Filter Results:
(558)
Show Results For
- All HBS Web
(558)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(558)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
developed at Minnesota’s Mayo Clinic. Kevin Bennet (MBA 1980) chairs the hospital’s 102-year-old engineering department, where some of the first machines designed to keep patients alive during open-heart surgery were developed. Today,... View Details
Keywords: Janelle Nanos
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug View Details
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A pioneer in the View Details
- 27 Nov 2017
- Research & Ideas
Beware the Lasting Impression of a 'Temporary' Selfie
a prop, or exhibited nudity, drinking, or drug use. As to the impact on observers of the posts, the temporary-sharers were characterized as having worse judgment than those who shared in permanent mediums. That belief was underscored... View Details
Keywords: by Rachel Layne
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
companies feared that the precedent set by the South African move would undermine their control over valuable intellectual property in the developing world. But the suit sparked international outrage against the industry, prompting a very... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 01 Feb 2000
- News
Bart Harvey: Opportunities for Others
even as he enjoyed a successful career as a high-flying real-estate dealmaker at Dean Witter Reynolds. Then he was introduced to the late James Rouse, the visionary developer who founded the Enterprise Foundation in 1982. "Jim Rouse... View Details
- Web
Market Perspectives - Course Catalog
cases explore concrete situations that highlight the challenges and tradeoffs of decision-makers. Issues explored include: education, urban development, illegal drugs, rent control, housing, drug pricing, racial references, corporate... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill costs 5 cents to manufacture,... View Details
Keywords: by Max H. Bazerman
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
- Portrait Project
Sarah Assayag
I would become the first colony settler on Earth 2.0, develop drugs that would allow humans to become immortal, and create an android that would fall asleep by counting electric sheep. My 8-year-old self,... View Details
- Profile
Terrance McGuire
measured in multiple years rather than months. A high tech startup can see a marketplace, introduce a product and know pretty accurately whether its customers are going to purchase and use a product or service. A biotech venture might wait a decade before a promising... View Details
- 17 Feb 2016
- Blog Post
Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference
markets, to changing the drug discovery process to be more patient-centric. A highlight of the panel sessions was when Adam Koppel, EVP of Strategy and Corporate Development at Biogen and Health Care... View Details
Keywords: Health Care
- 01 Jun 2012
- News
Inspiration Is Not Enough
animated screen stars for decades of royalty income. IKEA founder Ingvar Kamprad developed a rigorous vendor-screening process that, though not sexy, provided the furniture retailer with “an impressive supply chain that is virtually... View Details
- 04 Oct 2016
- Blog Post
Why We Recruit: CVS Health
of health. Through its approximately 9,600 retail pharmacies under the CVS, Navarro and Longs Drugs brand names, more than 1,135 walk-in MinuteClinc locations, a leading pharmacy benefits manager with more than 75 million plan members, a... View Details
Keywords: Health Care
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- Student-Profile
A Jay Holmgren
A Jay Holmgren (he/him) hadn’t yet developed a strong interest in health policy when he graduated from the University of Michigan with a BA in History in 2011. But when his father was diagnosed with cancer in 2014, A Jay found himself... View Details
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
Hansjörg Wyss (MBA 1965) has been unusually public of late, celebrated for his visionary accomplishments in health care and conservation. Wyss, 75, founded Synthes USA, a Swiss-American firm, in 1974 and led it to global prominence as a pioneer in the View Details
- 30 Mar 2010
- First Look
First Look: March 30
GordonHarvard Business School Case 810-066 In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic... View Details
Keywords: Sean Silverthorne
- 19 Oct 2023
- Blog Post
New Venture Competition 2023: Business and Environment Ventures
entrants, and we wanted to highlight the contestants from this year’s competition who are developing a wide range of ventures to address climate change. WINNER: Tough Tech: Most Promising Climate Tech Venture $5,000 Prize Grensol - Rajiv... View Details